CytoSure™ Molecular Arrays
Reliable detection of copy number changes for research into a range of genetic disorders. CytoSure Molecular Arrays are designed to accurately identify small intragenic copy number variations (CNVs) in genes associated with a variety of disorders. The content for each array has been designed and optimised in collaboration with leading molecular genetics experts at Emory University. In addition to pre-designed catalogue arrays…
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Reliable detection of copy number changes for research into a range of genetic disorders.
CytoSure Molecular Arrays are designed to accurately identify small intragenic copy number variations (CNVs) in genes associated with a variety of disorders. The content for each array has been designed and optimised in collaboration with leading molecular genetics experts at Emory University. In addition to pre-designed catalogue arrays, you can also utilise our extensive array design expertise to produce custom arrays matching your precise specifications.
CytoSure™ Molecular Arrays Features:
- Accurate detection of copy number variation — a perfect complement to sequencing analysis
- Array content fully optimised and research-validated by Emory University
- Flexible array content and formats — create the ideal array for your needs
- Cost-effective processing — multiple molecular disorders can be included in a single array
- Easy data interpretation using optimised protocols and industry-leading CytoSure Interpret Software
Comprehensive Genomic Analysis – Complementing Sequencing with High-Resolution CNV Detection
This white paper will discuss the role of these molecular arrays as part of their complete investigation framework, and how such an integrated approach presents the next stage of molecular testing in clinical genetics research. To provide real-world examples, this approach is also discussed in the context of two case studies.
Comprehensive Genomic Analysis – Complementing Sequencing with High-Resolution CNV Detection
This white paper discusses the role of these molecular arrays as part of their complete investigation framework, and how such an integrated approach presents the next stage of molecular testing in clinical genetics research. To provide real-world examples, this approach is also be discussed in the context of two case studies.
ASHG 2013 workshop: Complementing next generation sequencing experiments with high-resolution copy number variation detection
Mike Evans, CEO of Oxford Gene Technology introduced Professor Madhuri Hegde of the Emory Genetics Lab, talking at the American Society for Human Genetics (ASHG) 2013 meeting in Boston.
